AU Patent

AU2001253334A1 — Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2001-10-23 · 25y expired

What this patent protects

Patent listed against chembl-chembl428647.

Drugs covered by this patent

chembl-chembl428647 (PACLITAXEL)

Patent Metadata

Patent number: AU2001253334A1
Jurisdiction: AU
Classification: —
Expires: 2001-10-23
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.